Michael Scolaro

Michael Scolaro

Sep 27, 2017

Group 6 Copy 104
2
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

MyHealthEd

Each child deserves quality comprehensive sexual health education. No child is the same, so why should...

Can Data Management Tools Improve Research Efficiency and Reproducibility?

Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

kwiKBio: Empowering citizen scientist superheroes to cure disease

My mother has Alzheimer's. My father suffered a stroke. A close friend's daughter, cystic fibrosis. My cousin...

Backer Badge Funded